(FY)Dec 30, 2023 | (FY)Dec 30, 2022 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | 42.00%-1.16M | -2M |
Other cash income from operating activities | 42.00%-1.16M | ---2M |
Cash paid | ||
Operating cash flow | 42.00%-1.16M | ---2M |
Investing cash flow | ||
Cash flow from continuing investing activities | 15K | |
Net PPE purchase and sale | --15K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | --15K | ---- |
Financing cash flow | ||
Cash flow from continuing financing activities | -76.78%498.76K | 2.15M |
Net issuance payments of debt | --498.76K | ---- |
Net common stock issuance | ---- | --2.38M |
Net other financing activities | ---- | ---233.15K |
Cash from discontinued financing activities | ||
Financing cash flow | -76.78%498.76K | --2.15M |
Net cash flow | ||
Beginning cash position | 69.04%1.44M | --852.6K |
Current changes in cash | -549.19%-648.28K | --144.32K |
Effect of exchange rate changes | 210.88%18.51K | ---16.69K |
Cash adjustments other than cash changes | ---- | --244.908 |
End cash Position | -17.24%811.47K | --980.48K |
Free cash from | 42.00%-1.16M | ---2M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data